Malignant Breast Neoplasm — Trials

Malignant Breast Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,627
Recruiting: 1,400
Ph III recruiting: 154
Growth YoY: +20.8%
Industry share: 18%
Top sponsor: Fudan University
Termination share: 25.6%
Trials / 1,000 deaths: 61.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,368)

clinicaltrialsPublishedShowing 201–250 of 3,552 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07631052	Capecitabine in ER+/HER2-negative Breast Cancer	recruiting	Phase 2	15	University Health Network, TorontoOTHER	1	Aug 18, 2026	clinicaltrials
NCT01266642	Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer	active not recruiting	Phase 2	301	M.D. Anderson Cancer CenterOTHER	1	Aug 17, 2026	clinicaltrials